Advertisement
Canada markets close in 3 hours 34 minutes

  • S&P/TSX

    21,986.19
    +100.81 (+0.46%)
     

  • S&P 500

    5,104.51
    +56.09 (+1.11%)
     

  • DOW

    38,255.70
    +169.90 (+0.45%)
     

  • CAD/USD

    0.7312
    -0.0012 (-0.16%)
     

  • CRUDE OIL

    84.04
    +0.47 (+0.56%)
     

  • Bitcoin CAD

    87,017.38
    -700.03 (-0.80%)
     

  • CMC Crypto 200

    1,320.19
    -76.34 (-5.23%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • RUSSELL 2000

    1,998.84
    +17.73 (+0.89%)
     

  • 10-Yr Bond

    4.6750
    -0.0310 (-0.66%)
     

  • NASDAQ

    15,936.09
    +324.33 (+2.08%)
     

  • VOLATILITY

    15.28
    -0.09 (-0.59%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6837
    +0.0016 (+0.23%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

Evogene: Q4 Earnings Snapshot

Associated Press
Updated ·1 min read

REHOVOT, Israel (AP) _ Evogene Ltd. (EVGN) on Wednesday reported a loss of $8.1 million in its fourth quarter.

The Rehovot, Israel-based company said it had a loss of 25 cents per share.

The agricultural company posted revenue of $351,000 in the period.

For the year, the company reported that its loss widened to $23.4 million, or 83 cents per share. Revenue was reported as $1 million.

Evogene shares have risen 26% since the beginning of the year. The stock has more than quadrupled in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EVGN at https://www.zacks.com/ap/EVGN